Table 1.
Baseline characteristics of overall patients n (%)
| Characteristic | Group A | Group B |
| (n = 37) | (n = 31) | |
| Sex | ||
| Male | 34 (91.9) | 26 (83.9) |
| Female | 3 (8.1) | 5 (16.1) |
| Age, yr (%) | ||
| ≥ 55 yr | 18 (48.9) | 14 (45.2) |
| < 55 yr | 19 (51.4) | 17 (54.8) |
| Type of tumor | ||
| Nodular | 30 (81.1) | 29 (93.5) |
| Infiltrative | 7 (18.9) | 2 (6.5) |
| HCC maximum diameter | ||
| ≥ 5 cm | 26 (70.3) | 19 (61.3) |
| < 5 cm | 11 (29.7) | 12 (38.7) |
| Degree of MPVTT | ||
| Stenosis | 31 (83.8) | 24 (77.4) |
| Occlusive | 6 (16.2) | 7 (22.6) |
| Child-pugh class | ||
| A | 33 (89.2) | 24 (77.4) |
| B | 4 (10.8) | 7 (22.6) |
| ECOG performance status | ||
| 0/1 | 33 (89.2) | 26 (83.9) |
| 2 | 4 (10.8) | 5 (16.1) |
| Etiology of liver disease | ||
| HBV | 35 (94.6) | 29 (93.5) |
| Other | 2 (5.4) | 2 (6.5) |
| Serum AFP level (in ng/mL) | ||
| ≥ 400 | 20 (54.1) | 17 (54.8) |
| < 400 | 17 (45.9) | 14 (45.2) |
| Extrahepatic metastasis | 3 (8.1) | 3 (9.7) |
AFP: Alfa-fetoprotein; ECOG: Eastern cooperative oncology group; HBV: Hepatitis B virus; MPVTT: Main portal vein tumor thrombus; HCC: Hepatocellular carcinoma.